中文BIGBEAR Pharmaceutical announces the approval of baricitinib and selumetinib in Laos
Vientiane, Laos - April 8, 2024 - BigBear Pharma, a leading biopharmaceutical co
Big Bear Pharmaceutical Announces Trelagliptin and Ivosidenib Approved in Laos
Laos Vientiane-January 03, 2024-BigBear Pharma, a leading alchemon company focus
Laos BigBear Pharmaceuticals successfully obtained GMP certification for traditional medicine processing plant
Laos BigBear Pharmaceuticals successfully obtained GMP certification for traditi
Big Bear Pharmaceutical Announces Selpercatinib Entrectinib and Enasidenib Approved in Laos
Laos Vientiane-October 11, 2023-BigBear Pharma, a leading alchemon company focus
Big Bear Pharmaceutical Announces Pomalidomide and Pemigatinib Approved in Laos
Laos Vientiane-October 10, 2023-BigBear Pharma, a leading alchemon company focusing on development and commercial cancer innovation therapy, announced today that two products have been approved by the
BigBear Pharmaceutical announced that Eltrombopag was approved in Laos
Vientiane, Laos - September 22, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative treatments for cancer, announced today that Cabozantini
Big Bear Pharmaceutical Announces Isazomib, Lenalidomide, Mitotane, Tofacitinib, Tucatinib, Deucravacitinib and Upadatin
Vientiane, Laos - August 22, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative treatments for cancer, announced today that seven products
Lao Food and Drug Administration came to Big Bear Pharma to inspect and guide the traditional medicine factory
VIENTIANE, VIENTIANE, LAO PDR, June 28, 2023 Lao Food and Drug Administration came to Big Bear Pharma to inspect and guide the traditional medicine factory. The investor team of Big Bear Pharmaceutica
BigBear Pharmaceutical announced that Ibrutinib and Erdafitinib were approved in Laos
Vientiane, Laos - August 01, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative treatments for cancer, announced today that two products h
BigBear Pharmaceutical announced that Osimertinib, Mobocertinib, Avatrombopag and Acalabrutinib were approved in Laos
Vientiane, Laos - July 04, 2023 - Big Bear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative treatments for cancer, announced today that four products ha